Aguilar et al. recently reported finding that advanced‐NSCLC patients with very high PD‐L1 expression (TPS 90%–100%) had a significantly higher objective response rate (ORR) and a significantly longer mPFS and mOS than those with a PD‐L1 expression TPS of 50%–89%.6 Here, CD274 is linked to non-small cell lung carcinoma.